Last10K.com

Eyenovia, Inc. (EYEN) SEC Filing 8-K Material Event for the period ending Wednesday, May 5, 2021

Eyenovia, Inc.

HISTORY TOOLS
CIK: 1682639 Ticker: EYEN

View differences made from one to another to evaluate Eyenovia, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Eyenovia, Inc..

Continue

Assess how Eyenovia, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Eyenovia, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Eyenovia, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: EYEN
CIK: 1682639
Form Type: 8-K Corporate News
Accession Number: 0001104659-21-061403
Submitted to the SEC: Wed May 05 2021 8:32:50 AM EST
Accepted by the SEC: Wed May 05 2021
Period: Wednesday, May 5, 2021
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/eyen/0001104659-21-061403.htm